15 June 2025
Diabetic eye screening is a vital front line in preventing sight loss from diabetic retinopathy (DR). With approximately 4 million people enrolled in the NHS Diabetic Eye Screening Programme and around 3.3 million receiving routine imaging every, one to two years, it’s clear this service forms the backbone of ocular healthcare for people with diabetes in the UK. However, with mounting pressure from rising patient numbers and mounting expectancies, clinics need to adopt cutting-edge technologies and efficient workflows to stay ahead.
Digital fundus cameras capture colour retinal images that feed seamlessly into screening pathways like routine digital screening (RDS) and digital surveillance (DS). These images are graded swiftly, aiding early detection of referable retinopathy, which affects roughly 3.2% of screened eyes. Investing in robust systems reduces ungradable rates (currently averaging 3-3.1%) and improves screening accuracy.
OCT takes imaging to another dimension, literally, capturing detailed cross-sections of the retina in 3D. NHS England estimates that rolling out OCT in community settings could prevent 120,000 hospital appointments annually. OCT excels in detecting early retinal thickening and macular oedema, conditions often missed by fundus photography alone. Its integration enables timely community-based interventions and significant hospital burden relief.
Clinics need efficient software platforms to manage invitations, screening appointments, grading and referrals. NHS standards like DES-PS01 ensure that invitations for new patients are sent within 89 days of diagnosis. Digital platforms that merge patient data, appointment scheduling, grading and notices to GPs or ophthalmologists can dramatically reduce administrative delays and help maintain compliance with NHS performance thresholds.
Not all patients need annual screening. Those with no signs of DR might safely extend their screening interval to 24 months. Data from recent studies show that DR detection remained stable – 3.1% to 3.2% referable DR – even when intervals were lengthened post-COVID prioritisation. Utilising intelligent algorithms to distinguish low-risk from high-risk patients allows clinics to focus resources where they’re needed, lowering cost and increasing capacity.
Deploying mobile or GP-based screening with portable fundus cameras and OCT improves accessibility and convenience for patients. NHS digital screening rollouts in community settings are already delivering results, detecting early disease promptly and saving hospital appointments.
For eye care professionals in both private optician practices and NHS settings, integrating advanced imaging modalities like fundus photography and OCT, backed by streamlined digital workflows, is no longer optional – it’s essential.
Sense Medical, as a leading distributor of Canon ophthalmic equipment, is ideally positioned to help practices elevate their diabetic eye screening programme. By offering training and seamless integration with NHS standards, clinics can protect vision, reduce patient burden, and contribute to a sustainable, technology-driven future in ocular health.
